Prospera Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Buy
3,001
+243
+9% +$20.4K ﹤0.01% 1273
2026
Q1
$221K Buy
2,758
+57
+2% +$4.7K ﹤0.01% 1325
2025
Q4
$230K Buy
+2,701
New +$222K ﹤0.01% 1244
2025
Q1
Sell
-2,704
Closed -$200K 1187
2024
Q4
$200K Buy
+2,704
New +$189K ﹤0.01% 1086
2024
Q3
Sell
-3,072
Closed -$284K 1140
2024
Q2
$284K Buy
3,072
+158
+5% +$14K 0.01% 943
2024
Q1
$278K Buy
+2,914
New +$245K 0.01% 928
2023
Q3
Sell
-22,070
Closed -$2.08M 1025
2023
Q2
$2.08M Sell
22,070
-5,333
-19% -$464K 0.08% 260
2023
Q1
$2.27M Sell
27,403
-1,081
-4% -$85K 0.09% 256
2022
Q4
$2.13M Buy
28,484
+1,315
+5% +$101K 0.11% 221
2022
Q3
$2.25M Buy
27,169
+823
+3% +$79.2K 0.12% 215
2022
Q2
$2.5M Sell
26,346
-977
-4% -$101K 0.13% 200
2022
Q1
$3.22M Buy
27,323
+1,442
+6% +$162K 0.13% 183
2021
Q4
$3.35M Buy
25,881
+3,170
+14% +$370K 0.14% 169
2021
Q3
$2.57M Buy
22,711
+3,702
+19% +$423K 0.13% 193
2021
Q2
$1.97M Buy
19,009
+286
+2% +$27K 0.1% 245
2021
Q1
$1.57M Buy
18,723
+16,504
+744% +$1.4M 0.09% 256
2020
Q4
$202K Buy
2,219
+1,100
+98% +$91.2K 0.01% 642
2020
Q3
$89K Buy
+1,119
New +$87.3K 0.03% 436
2020
Q1
Sell
-2,616
Closed -$203K 547
2019
Q4
$203K Buy
+2,616
New +$204K 0.02% 565

Other funds holding EW

Prospera Financial Services's EW Position: Q2 2026 in Review

Prospera Financial Services increased its Edwards Lifesciences (EW) stake by 8.8% in Q2 2026, buying an estimated $20.4K and bringing the position to 3,001 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Prospera Financial Services first reported a position in EW in Q4 2019 and has held it in 19 quarters since. The position peaked at $3.35M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Prospera Financial Services held 3,001 shares of Edwards Lifesciences worth $271K as of Q2 2026.
  • Prospera Financial Services bought 243 Edwards Lifesciences shares in Q2 2026, an estimated $20.4K.
  • Edwards Lifesciences made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1273 holding.
  • Prospera Financial Services first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 19 quarters since.
  • Prospera Financial Services's Edwards Lifesciences position peaked at $3.35M in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.